ZIMMER’S PATIENT SPECIFIC SHOULDER SYSTEM CLEARED FOR U.S (Orthopedics This Week)
The FDA has given Zimmer Holdings, Inc. permission to market the company’s Patient Specific Instruments (PSI) Shoulder System for reverse shoulder arthroplasty procedures (RSA).
The system enables surgeons to plan the implant size and position, as well as bone preparation, including positioning the screw. It does this by utilizing 3D visualization software. European patients and surgeons have had access to the system since last May.
In an August 23, 2013 press release announcing the FDA clearance, Robert Munoz, vice president and general manager for Zimmer Extremities, said the primary challenges with reverse shoulder arthroplasty remain on the glenoid. “With PSI Shoulder, we present our surgeon customers with a powerful new tool to plan the glenoid side of the surgery with the patient’s unique anatomy in full view and functional needs in mind, resulting in a physical reference in the operating room to complete the surgery with confidence.”
“Zimmer’s PSI Shoulder makes you look at the patient in an entirely different way,” said Dr. Olivier Verborgt, of AZ-Monica hospital, Antwerp Belgium, who has per...
